Iberogast (Milk Thistle Fruit Extract, Bitter Candytuft Fresh Plant Extract, Matricaria Liquid Extract, Menthae)

Iberogast combines several plant extracts that together provide spasmolytic, anti‑inflammatory and pro‑kinetic actions. These effects relax smooth muscle, reduce mucosal inflammation and promote normal gut motility, helping to alleviate pain, bloating and irregular bowel movements.

The dosage of Iberogast is determined by the prescribing healthcare professional based on the individual’s condition, age and response. Typical adult regimens involve several milliliters taken several times daily, but the exact amount should follow the prescriber’s instructions.

Safety data for Iberogast in pregnancy and lactation are limited. It should only be used if the potential benefit justifies any possible risk, and this decision must be made in consultation with a qualified healthcare provider.

To order Iberogast, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with conventional pro‑kinetic agents such as domperidone, Iberogast offers a multi‑herbal approach that targets several pathways simultaneously. While conventional drugs act on specific receptors, Iberogast’s blend provides combined spasmolytic, anti‑inflammatory and motility‑enhancing effects, which may be preferred by patients seeking a non‑synthetic option.

Iberogast should be stored at ambient temperature, preferably below 25 °C, in its original packaging. Protect the product from excessive moisture, direct sunlight and extreme temperatures to maintain its stability and potency.

Iberogast is supplied as an oral liquid. The prescribed volume is measured using a calibrated dropper or measuring cup and taken by mouth, usually several times a day, as directed by the treating clinician.

The most serious risks include severe allergic reactions such as anaphylaxis, significant liver enzyme elevations, pancreatitis and rare severe skin reactions. Patients should seek immediate medical attention if they experience symptoms like rash, swelling, jaundice, abdominal pain or unexplained bleeding.

Iberogast should be avoided by individuals with known hypersensitivity to any of its herbal components, patients with severe liver disease, and children unless specifically advised by a pediatric specialist. Consultation with a healthcare professional is essential before initiating therapy.